Skip links

Gene Therapy for ‘Haemophilia A’

Gene Therapy for ‘Haemophilia A’ IAS TOPPERS

India has conducted the first human clinical trial of gene therapy for ‘Haemophilia A’ at Christian Medical College.

Gene Therapy for ‘Haemophilia A’
[ref-Live Science]

What is Gene therapy?

  • Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use.
  • It is a technique that modifies a person’s genes to treat or cure diseases.
  • It can work by several mechanisms:
    • Replacing a disease-causing gene with a healthy copy of the gene.
    • Inactivating a disease-causing gene that is not functioning properly.
    • Introducing a new or modified gene into the body to help treat a disease.
  • Gene therapy is currently used to treat certain blood cancers, such as B-cell acute lymphoblastic leukaemia.

How does gene therapy work?

  • Gene therapy works by altering the genetic code to recover the functions of critical proteins.
  • Proteins serve as the cellular workhorses and form the structural foundation of the body’s tissues.
  • The instructions for protein synthesis are encoded in a person’s genetic code, and variations or mutations in this code can affect the production or function of crucial proteins necessary for the body’s proper functioning.
  • Addressing or compensating for disease-causing genetic changes can restore the role of these vital proteins, enabling the body to function as intended.

Approaches to genetic alterations:

Gene transfer therapy

  • Gene transfer therapy involves introducing new genetic material into cells.
  • If an altered gene results in a defective or missing necessary protein, gene transfer therapy can insert a normal copy of the gene to restore protein function.
  • Alternatively, this therapy may introduce a different gene providing instructions for a protein that aids normal cell function, irrespective of the genetic alteration.

Genome editing:

  • Genome editing is a newer technique applicable to gene therapy.
  • Instead of adding new genetic material, genome editing employs gene-editing tools that can modify the existing DNA within cells.
  • These technologies enable the addition, removal, or alteration of genetic material at precise locations in the genome, with CRISPR-Cas9 being a well-known type of genome editing.

Types of gene therapy:

  • Plasmid DNA: Circular DNA molecules can be genetically engineered to carry therapeutic genes into human cells.
  • Viral vectors: Viruses have a natural ability to deliver genetic material into cells, and therefore some gene therapy products are derived from viruses.
    • Once viruses have been modified to remove their ability to cause infectious disease, these modified viruses can be used as vectors (vehicles) to carry therapeutic genes into human cells.
  • Bacterial vectors: Bacteria can be modified to prevent them from causing infectious disease and then used as vectors (vehicles) to carry therapeutic genes into human tissues.
  • Human gene editing technology: The goals of gene editing are to disrupt harmful genes or to repair mutated genes.
  • Patient-derived cellular gene therapy products: Cells are removed from the patient, genetically modified (often using a viral vector) and then returned to the patient.

About Haemophilia A:

  • Haemophilia A, also known as classical Haemophilia  or factor VIII (8) deficiency, is a hereditary bleeding disorder.
  • Haemophilia is characterized by a deficiency in blood clotting.
  • It is caused by a mutation on the X-chromosome’sFactor VIII (HEMA) gene, which means that only boys are affected.
    • The X chromosome contains genes that produce clotting factor proteins, which are necessary for blood clotting.
  • The mother is a carrier of the disease, and in most cases, this mutation is passed on from parent to child.

How is Haemophilia A passed on?

  • The X and Y sex chromosomes help determine Haemophilia inheritance patterns.
  • The gene for Haemophilia is carried on the X chromosome.
  • Haemophilia is inherited in an X-linked recessive manner.
  • Females inherit two X chromosomes, one from their mother and one from their father (XX). Males inherit an X chromosome from their mother and a Y chromosome from their father (XY).
  • That means if a son inherits an X chromosome carrying Haemophilia from his mother, he will have Haemophilia.
  • It also means that fathers cannot pass Haemophilia on to their sons.
  • Because daughters have two X chromosomes, even if they inherit the hemophilia gene from their mother, most likely they will inherit a healthy X chromosome from their father and not have haemophilia.

Ref:Source

UPSC IAS Preparation Resources
Current Affairs AnalysisTopperspedia
GS ShotsSimply Explained
Daily Flash CardsDaily Quiz